Bitcoin (BTC) has risen roughly 9% this week, indicating solid buying by the bulls. The up move is facing resistance near $69,000 but the bulls are not exiting their positions in a hurry. That ...

Dogecoin (DOGE) remains one of the most closely watched cryptocurrencies, known for its volatility and popularity among ...

According to Sudeep Shah, given the technical weakness, FMCG and Auto sectors are likely to underperform in the near term.

EMA committee recommends marketing approval for Novartis’ Kisqali to help reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Saturday, October 19, 202 ...

UK Retail Sales bounced 0.3% in September, falling back from August’s 1.0% but still sticking well above the expected -0.3% ...

Currently, Bitcoin trades around $67,600, opening the door for further gains. Analysts suggest Bitcoin could reach $75,000 by ...

The European Medicines Agency’s human medicines committee again decided not to recommend the renewal of the conditional ...

The European Medicines Agency has recommended Korjuny for the treatment of patients with intraperitoneal malignant ascites.

If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible for adjuvant treatment ...

AB Science SA (Euronext - FR0010557264 - AB) today announces that the European Medicines Agency (EMA) confirmed a negative opinion for ... often lethal with short term survival or rare or refractory ...

Aptos (APT) surged 24%, but mixed technical signals raise concerns about sustaining the rally, with weakening bullish momentum.

Bitcoin price successfully closes above the $66,000 resistance level, eyeing a rally ahead. Ethereum price bounces off its ...